Predictors of response to galcanezumab in patients with chronic migraine: a real-world prospective observational study.

Hyoung Cheol LeeSoohyun ChoByung-Kun Kim

Published in: Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology (2023)

Our real-world data showed the efficacy of galcanezumab in patients with CM, regardless of medication overuse. Everyday headache, presence of depression, and absence of accompanying symptoms of migraine were significant predictors of a poor response.

Keyphrases

sleep quality
depressive symptoms
healthcare
electronic health record
emergency department
physical activity
data analysis
deep learning
artificial intelligence